Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) Short Interest Up 451.9% in April

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totaling 70,535 shares, an increase of 451.9% from the April 15th total of 12,780 shares. Based on an average trading volume of 113,858 shares, the short-interest ratio is currently 0.6 days. Approximately 0.1% of the company’s stock are sold short.

Xtant Medical Stock Performance

Shares of XTNT stock opened at $0.50 on Wednesday. Xtant Medical has a 12 month low of $0.44 and a 12 month high of $0.95. The company’s fifty day simple moving average is $0.55 and its 200-day simple moving average is $0.64. The firm has a market cap of $70.65 million, a PE ratio of 16.82 and a beta of -0.11. The company has a quick ratio of 1.63, a current ratio of 2.65 and a debt-to-equity ratio of 0.22.

Xtant Medical (NYSEAMERICAN:XTNT) last released its earnings results on Tuesday, March 31st. The medical device company reported $0.03 earnings per share for the quarter. Xtant Medical had a net margin of 3.71% and a return on equity of 10.27%. The business had revenue of $32.36 million during the quarter, compared to the consensus estimate of $30.75 million.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Craig Hallum reaffirmed a “buy” rating on shares of Xtant Medical in a research note on Wednesday, March 18th. BTIG Research dropped their price target on Xtant Medical from $1.50 to $1.00 and set a “buy” rating on the stock in a research note on Tuesday, March 31st. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Xtant Medical presently has a consensus rating of “Buy” and a consensus target price of $1.00.

Institutional Trading of Xtant Medical

Hedge funds and other institutional investors have recently modified their holdings of the stock. Jane Street Group LLC acquired a new position in shares of Xtant Medical during the 2nd quarter worth approximately $26,000. Mink Brook Asset Management LLC boosted its holdings in shares of Xtant Medical by 125.8% in the 2nd quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock valued at $81,000 after buying an additional 60,997 shares during the last quarter. Tradition Wealth Management LLC bought a new position in shares of Xtant Medical in the fourth quarter valued at $79,000. Wiregrass Investment Management LLC bought a new position in shares of Xtant Medical in the fourth quarter valued at $81,000. Finally, Vanguard Group Inc. increased its holdings in Xtant Medical by 4.6% during the third quarter. Vanguard Group Inc. now owns 2,355,671 shares of the medical device company’s stock worth $1,529,000 after buying an additional 104,159 shares during the last quarter. Institutional investors and hedge funds own 69.33% of the company’s stock.

Xtant Medical Company Profile

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.